3-Amino-5-(trifluoromethoxy)benzonitrile, 98%, 100mg

(4R)-4-[(1S,2S,5R,7R,10R,11S,14R,15R,16S)-5,16-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanoic acid, 99.5%, 5g

4-Bromo-1-(tert-butyl)-1H-pyrazole, 95.0%, 5g

1,3,4,6-Tetra-O-acetyl-2-O-(trifluoromethanesulfonyl)-beta-D-mannopyranose>98.0%(GC)100mg

4'-fluoro-3-(3,4,5-trifluorophenyl)propiophenone, 97.0%, 1g

tert-Butyl 7-amino-1-azaspiro[4.4]nonane-1-carboxylate, 98%, 100mg

Tert-butyl 4-(6-((8-cyclopentyl-5-methyl-7-oxo-6-(1-propoxyvinyl)-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate, 98%, 250mg

N-(Furan-2-ylmethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide, 98%, 1g

2-(5-Bromo-2-methylbenzyl)-5-(4-fluorophenyl)thiophene, 95.0%, 25g

Crisol de fusión ROTILABO® forma media alta, 20 ml, 5 Unidad(es)

(S)-4-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-5-amino-5-oxopentanoic acid, 95.0%, 25g

7-Chloroisoquinoline-1-carboxylic acid, 95.0%, 100mg

3-BROMO-1,1-DIFLUORO-CYCLOBUTANE, 95.0%, 10g